ATE403653T1 - Pyridin-substituierte furanderivate als raf- kinase inhibitoren - Google Patents

Pyridin-substituierte furanderivate als raf- kinase inhibitoren

Info

Publication number
ATE403653T1
ATE403653T1 AT02777001T AT02777001T ATE403653T1 AT E403653 T1 ATE403653 T1 AT E403653T1 AT 02777001 T AT02777001 T AT 02777001T AT 02777001 T AT02777001 T AT 02777001T AT E403653 T1 ATE403653 T1 AT E403653T1
Authority
AT
Austria
Prior art keywords
sub
sup
kinase inhibitors
raf
pyridine
Prior art date
Application number
AT02777001T
Other languages
English (en)
Inventor
Andrew Kenneth Takle
David Matthew Wilson
David Kenneth Dean
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0121485A external-priority patent/GB0121485D0/en
Priority claimed from GB0121493A external-priority patent/GB0121493D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE403653T1 publication Critical patent/ATE403653T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02777001T 2001-09-05 2002-09-05 Pyridin-substituierte furanderivate als raf- kinase inhibitoren ATE403653T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0121485A GB0121485D0 (en) 2001-09-05 2001-09-05 Compounds
GB0121493A GB0121493D0 (en) 2001-09-05 2001-09-05 Compounds

Publications (1)

Publication Number Publication Date
ATE403653T1 true ATE403653T1 (de) 2008-08-15

Family

ID=26246514

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02777001T ATE403653T1 (de) 2001-09-05 2002-09-05 Pyridin-substituierte furanderivate als raf- kinase inhibitoren

Country Status (6)

Country Link
US (1) US7375105B2 (de)
EP (1) EP1423383B1 (de)
AT (1) ATE403653T1 (de)
DE (1) DE60228098D1 (de)
ES (1) ES2309207T3 (de)
WO (1) WO2003022838A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02005106A (es) * 1999-11-22 2002-11-07 Smithkline Beecham Plc Compuestos novedosos.
EP1263753B1 (de) * 2000-03-06 2004-05-06 SmithKline Beecham plc Imidazol derivate als raf kinase inhibitoren
GB0112348D0 (en) * 2001-05-19 2001-07-11 Smithkline Beecham Plc Compounds
WO2003022837A1 (en) * 2001-09-05 2003-03-20 Smithkline Beecham P.L.C. Heterocycle-carboxamide derivatives as raf kinase inhibitors
US7827944B2 (en) * 2006-06-30 2010-11-09 Gm Global Technology Operations, Inc. System for controlling the response time of a hydraulic system
JP5352476B2 (ja) 2007-06-05 2013-11-27 武田薬品工業株式会社 キナーゼ阻害剤としての二環式複素環化合物
SG183036A1 (en) 2007-07-17 2012-08-30 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
JP5270553B2 (ja) 2007-08-23 2013-08-21 武田薬品工業株式会社 複素環化合物およびその用途
EP2184285B1 (de) 2007-08-29 2015-11-04 Takeda Pharmaceutical Company Limited Heterocyclische verbindung und ihre verwendung
EP2250160B1 (de) 2008-01-25 2015-11-11 Millennium Pharmaceuticals, Inc. Thiophen-derivate und ihre verwendung als phosphatidylinositol 3-kinase (pi3k) inhibitoren
JP5579619B2 (ja) 2008-12-01 2014-08-27 武田薬品工業株式会社 複素環化合物およびその用途
JO3101B1 (ar) 2008-12-02 2017-09-20 Takeda Pharmaceuticals Co مشتقات بنزوثيازول كعوامل مضادة للسرطان
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
CA2750935A1 (en) 2009-01-30 2010-08-12 Millennium Pharmaceuticals, Inc. Heteroaryls and their use as pi3k inhibitors
US9090601B2 (en) 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
NZ607087A (en) 2010-08-11 2015-05-29 Millennium Pharm Inc Heteroaryls as inhibitors of pi3k and for the treatment of proliferative, inflammatory, or cardiovascular disorders
WO2012021611A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
JP2013533318A (ja) 2010-08-11 2013-08-22 ミレニアム ファーマシューティカルズ， インコーポレイテッド ヘテロアリールおよびその使用
AR083450A1 (es) 2010-10-13 2013-02-27 Millennium Pharm Inc Heteroarilos y sus usos en el tratamiento de enfermedades proliferativas, inflamatorias o cardiovasculares
CA2908505A1 (en) 2013-03-29 2014-10-02 Avoscience, Llc Lipidic furan, pyrrole, and thiophene compounds for treatment of cancer, neurological disorders, and fibrotic disorders
US20170312246A1 (en) 2016-04-27 2017-11-02 Avoscience, Llc Lipidic furan, pyrrole, and thiophene compounds for use in the treatment of atrophic vaginitis
GB201706806D0 (en) 2017-04-28 2017-06-14 Sentinel Oncology Ltd Pharmaceutical compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735958A (en) 1986-12-22 1988-04-05 Warner-Lambert Company Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-substituted-1H-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one inhibitors of cholesterol biosynthesis
US5792778A (en) 1995-08-10 1998-08-11 Merck & Co., Inc. 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
US5776954A (en) 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
ID26328A (id) * 1997-12-22 2000-12-14 Bayer Ag Penghambat raf kinase menggunakan urea heterosiklik tersubstitusi aril dan heteroaril
US6432980B1 (en) * 1999-11-12 2002-08-13 Merck & Co., Inc. Aliphatic amine substituted piperidyl diaryl pyrrole derivatives as antiprotozoal agents
CA2390100C (en) * 1999-11-12 2010-01-05 Tesfaye Biftu Diaryl piperidyl pyrrole derivatives as antiprotozoal agents
MXPA02005106A (es) 1999-11-22 2002-11-07 Smithkline Beecham Plc Compuestos novedosos.
JP2002037784A (ja) * 2000-05-17 2002-02-06 Nikken Chem Co Ltd 新規チオフェンアミド化合物

Also Published As

Publication number Publication date
EP1423383B1 (de) 2008-08-06
ES2309207T3 (es) 2008-12-16
US20040248896A1 (en) 2004-12-09
DE60228098D1 (de) 2008-09-18
US7375105B2 (en) 2008-05-20
WO2003022838A1 (en) 2003-03-20
WO2003022838A8 (en) 2004-03-25
EP1423383A1 (de) 2004-06-02

Similar Documents

Publication Publication Date Title
ATE403653T1 (de) Pyridin-substituierte furanderivate als raf- kinase inhibitoren
ATE454152T1 (de) 2-aminopyrimidin-derivate als raf-kinase-hemmer
ATE300529T1 (de) Imidazolderivate als raf-kinase-inhibitoren
ATE362929T1 (de) Pyridinderivate als inhibitoren der raf-kinase
MY142915A (en) Rho-kinase inhibitors
TW200611907A (en) Fused heterocyclic compound
NZ533310A (en) Benzimidazoles useful as protein kinase inhibitors
NO20033385D0 (no) Fuserte heterocykliske forbindelser
DE60318177D1 (de) Rho-kinase inhibitoren
DE602004026047D1 (de) Hemmer der akt aktivität
AU2001235844A1 (en) Imidazol-2-carboxamide derivatives as raf kinase inhibitors
ATE266022T1 (de) Imidazol derivate als raf kinase inhibitoren
MX2007008308A (es) Derivados de n-(heteroaril)-1h-indol-2-carboxamidas y su utilizacion como ligandos del receptor vaniloide trpv1-.
TNSN08020A1 (en) 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
MXPA05009151A (es) Inhibidores de cinasa heterociclica.
EA200400475A1 (ru) Замещенные производные бензимидазола и их применение для лечения злокачественной опухоли
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
ATE336489T1 (de) Stickstoff enthaltende heterozyklen und ihre verwendung als raf inhibitoren
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
ATE276259T1 (de) Dihydroporphyrinderivate und ihre verwendung
WO2000043375A3 (de) Substituierte arylheterocyclen
DK1904502T3 (da) Antiarytmiske precursorforbindelser, fremgangsmåder til syntese og fremgangsmåder til anvendelse
EA200700098A1 (ru) Производные 4-арилморфолин-3-она, их получение и их применение в терапии
SG145573A1 (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties